Exosomal transfer of miR-1238 contributes to temozolomide-resistance in glioblastomaResearch in context

Exosomal transfer of miR-1238 contributes to temozolomide-resistance in glioblastomaResearch in context

Background: Although temozolomide (TMZ) resistance is a significant clinical problem in glioblastoma (GBM), its underlying molecular mechanisms are poorly understood. In this study, we identified the role of exosomal microRNAs (miRNAs) from TMZ-resistant cells as important mediators of chemoresistan...

Full description

Bibliographic Details
Main Authors:	Jianxing Yin, Ailiang Zeng, Zhuoran Zhang, Zhumei Shi, Wei Yan, Yongping You
Format:	Article
Language:	English
Published:	Elsevier 2019-04-01
Series:	EBioMedicine
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352396419301562

Similar Items

Exosomal transfer of long non-coding RNA SBF2-AS1 enhances chemoresistance to temozolomide in glioblastoma
by: Zhuoran Zhang, et al.
Published: (2019-04-01)

DNA-methylation-mediated activating of lncRNA SNHG12 promotes temozolomide resistance in glioblastoma
by: Chenfei Lu, et al.
Published: (2020-02-01)

Identification of a panel of genes as a prognostic biomarker for glioblastomaResearch in context
by: Fengfei Wang, et al.
Published: (2018-11-01)

H19 Functions as a Competing Endogenous RNA to Regulate EMT by Sponging miR-130a-3p in Glioma
by: Qi Hu, et al.
Published: (2018-10-01)

Nanocell-mediated delivery of miR-34a counteracts temozolomide resistance in glioblastoma
by: Muhammad Babar Khan, et al.
Published: (2021-03-01)

Altered Expressions of miR-1238-3p, miR-494, miR-6069, and miR-139-3p in the Formation of Chronic Brucellosis
by: Ferah Budak, et al.
Published: (2016-01-01)

Immune checkpoint molecule herpes virus entry mediator is overexpressed and associated with poor prognosis in human glioblastomaResearch in context
by: Ming-Zhi Han, et al.
Published: (2019-05-01)

MAHMUD TÂRÂBÎ İSYANI (1238) [MAHMUD TARABI REBELLION (1238)]
by: Aykut ÖZBAYRAKTAR
Published: (2017-12-01)

MiR-181b suppress glioblastoma multiforme growth through inhibition of SP1-mediated glucose metabolism
by: JianXing Yin, et al.
Published: (2020-03-01)

miR-17-5p-CXCL14 axis related transcriptome profile and clinical outcome in diffuse gliomas
by: Ailiang Zeng, et al.
Published: (2018-12-01)

Preclinical Evidence of STAT3 Inhibitor Pacritinib Overcoming Temozolomide Resistance via Downregulating miR-21-Enriched Exosomes from M2 Glioblastoma-Associated Macrophages
by: Hao-Yu Chuang, et al.
Published: (2019-07-01)

ADAM17 Confers Temozolomide Resistance in Human Glioblastoma Cells and miR-145 Regulates Its Expression
by: Chen, J.-C, et al.
Published: (2023)

circFMN2 Sponges miR-1238 to Promote the Expression of LIM-Homeobox Gene 2 in Prostate Cancer Cells
by: Guangyi Shan, et al.
Published: (2020-09-01)

Quinacrine enhances temozolomide cytotoxicity in temozolomide-sensitive and -resistant glioblastoma cells
by: Pingde Zhang, et al.
Published: (2018-01-01)

Exosome and Melatonin Additively Attenuates Inflammation by Transferring miR-34a, miR-124, and miR-135b
by: June Seok Heo, et al.
Published: (2020-01-01)

Temozolomide antagonizes oncolytic immunovirotherapy in glioblastoma
by: Dipongkor Saha, et al.
Published: (2020-06-01)

Strategies of temozolomide in future glioblastoma treatment
by: Lee CY
Published: (2017-01-01)

Mechanism of acquired temozolomide resistance in glioblastoma
by: McFaline-Figueroa, José L
Published: (2014)

MiR-126 in intestinal-type sinonasal adenocarcinomas: exosomal transfer of MiR-126 promotes anti-tumour responses
by: Marco Tomasetti, et al.
Published: (2018-09-01)

Considering the Experimental use of Temozolomide in Glioblastoma Research
by: Verena J. Herbener, et al.
Published: (2020-06-01)

Temozolomide and Other Alkylating Agents in Glioblastoma Therapy
by: Hannah Strobel, et al.
Published: (2019-09-01)

Repurposing Penfluridol in Combination with Temozolomide for the Treatment of Glioblastoma
by: Hyungsin Kim, et al.
Published: (2019-09-01)

Potential Therapeutic Effects of Exosomes Packed With a miR-21-Sponge Construct in a Rat Model of Glioblastoma
by: Hamideh Monfared, et al.
Published: (2019-08-01)

The miR155HG/miR-185/ANXA2 loop contributes to glioblastoma growth and progression
by: Weining Wu, et al.
Published: (2019-03-01)

Glioblastoma stem cell (GSC)-derived PD-L1-containing exosomes activates AMPK/ULK1 pathway mediated autophagy to increase temozolomide-resistance in glioblastoma
by: Yong Zheng, et al.
Published: (2021-03-01)

MiR-221 and miR-222 target PUMA to induce cell survival in glioblastoma
by: Zhang Chun-Zhi, et al.
Published: (2010-09-01)

Reveal the involvement of CEBPD in stemness and Temozolomide resistance of glioblastoma
by: Wen-ChiLin, et al.
Published: (2018)

Nanoparticle Drug Delivery Systems for Temozolomide in the Treatment of Glioblastoma
by: Malini Honavar Melo Pires
Published: (2019)

Investigation of Temozolomide-resistant and sensitive clones in human glioblastoma
by: WU, YI-PING, et al.
Published: (2017)

Are There Thresholds in Glioblastoma Cell Death Responses Triggered by Temozolomide?
by: Yang He, et al.
Published: (2019-03-01)

Advances in the management of glioblastoma: the role of temozolomide and MGMT testing
by: Thomas RP, et al.
Published: (2012-12-01)

Integrins and p53 pathways in glioblastoma resistance to temozolomide
by: Monique eDontenwill, et al.
Published: (2012-10-01)

Senescence Is the Main Trait Induced by Temozolomide in Glioblastoma Cells
by: Beltzig, L., et al.
Published: (2022)

Aspergillosis in a Patient Receiving Temozolomide for the Treatment of Glioblastoma
by: Rodrigo Ramella Munhoz, et al.
Published: (2013-08-01)

Glioblastoma-Associated Microglia Reprogramming Is Mediated by Functional Transfer of Extracellular miR-21
by: Erik R. Abels, et al.
Published: (2019-09-01)

Interplay of m6A and histone modifications contributes to temozolomide resistance in glioblastoma
by: Fuxi Li, et al.
Published: (2021-09-01)

Combining Bevacizumab with Temozolomide Increases the Antitumor Efficacy of Temozolomide in a Human Glioblastoma Orthotopic Xenograft Model
by: Véronique Mathieu, et al.
Published: (2008-12-01)

Exosomal Transfer of Macrophage-Derived miR-223 Confers Doxorubicin Resistance in Gastric Cancer
by: Gao H, et al.
Published: (2020-11-01)

Dysregulation of exosomal miR-192 and miR-194 expression in lung adenocarcinoma patients
by: Tongfei Wang, et al.
Published: (2021-03-01)

Delivery of Functional Anti-miR-9 by Mesenchymal Stem Cell–derived Exosomes to Glioblastoma Multiforme Cells Conferred Chemosensitivity
by: Jessian L Munoz, et al.
Published: (2013-01-01)

Cannot write session to /tmp/vufind_sessions/sess_2me54918itvra3gnebbs2t6so2